Cramer's 'Mad Money' Recap: Caution Is King

Click here for an archive of Cramer's "Mad Money" recaps.

---

"The watchword for this market is 'caution'," Jim Cramer told viewers of his "Mad Money" TV show Monday.

He cautioned viewers that the general direction of the market is lower, not higher, and that a buy-and-hold strategy will not work in this environment.

"We're no longer in a market where stocks are innocent until proven guilty," he said. Instead, the market is treating all stocks as guilty until they prove themselves innocent and worthy of investors' money.

Cramer said the market won't reach a bottom until there is at least one run on a bank, where customers start lining up to withdraw all of their money in true panic fashion. He predicted several runs on banks in the coming weeks and months.

In this tough market, he said, "Investors need to accept the negativity, but not the panic." He reiterated that investors' goals should be capital preservation, not capital appreciation.

"When you can't make more money, the goal should be to lose less money than the next guy," he said.

Cramer outlined four situations where he'd feel comfortable buying a stock. First, he'd buy a stock where the market is so oversold that it creates a short rally. In that case, he warned, investors must take profits quickly.

Second, he'd buy a stock when all of the negativity is over. "But we're not there yet with any stock," he cautioned.

Third, he would buy stocks of companies with good earnings and a catalyst to get the stock price moving. After scanning over 1,000 stocks over the weekend, he found a few that meet these criteria.

And finally, he feels comfortable with stocks that have a safe dividend of more 4% and double-digit earnings growth.

A Silver Lining

Using a baseball analogy, Cramer told viewers that if they can't hit home runs in the current market, they should try to at least make it to first base on a single.

He then recommended Genentech (DNA Quote - Cramer on DNA - Stock Picks) as a pitch investors should swing at.

"Other than agriculture, oil and gold stocks, biotech has been one of the strongest groups in the market," he said.

Biotech, he said, is not sensitive to economic uncertainties and is loved by both Republicans and Democrats, which is essential for an election year. Of the major biotech players, he said Genentech has the biggest potential for earnings increases this year.

Although Gilead (GILD Quote - Cramer on GILD - Stock Picks) had been the sector's biggest performer, Genentech is now both cheaper than Gilead and has more upside potential, he said.

According to Cramer, the company has an analyst meeting Friday, at which time it could preannounce earnings, raise guidance, or make other stock-lifting announcements. "Any good news will matter," he said.

Cramer foresees Genentech's earnings between $4.10 and $4.20 a share. Giving the company a 24 multiple, he predicted a price target of $100 a share over the next 12 months.

That would constitute a 28% premium over its current price. "Not a home run," he said, "but not bad in a horrible market."

Down on Radio Stocks

Cramer once again voiced his outrage at the continued opposition to the proposed merger between Sirius Satellite (SIRI Quote - Cramer on SIRI - Stock Picks) and XM Satellite Radio (XMSR Quote - Cramer on XMSR - Stock Picks).

He blamed terrestrial radio and the National Association of Broadcasters for blocking a deal that would benefit both shareholders and consumers.

"Terrestrial radio is an industry that's falling apart," said Cramer, noting that the average market cap for terrestrial radio companies has declined 80% over the past five years.

« Previous Page

1 2

Next Page »